|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.10 CHF | -1.52% |
|
-1.19% | +12.32% |
| 10:40am | Novartis Q2 profit up as generic competition mounts | RE |
| 10:30am | Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed | DJ |
Broker Recommendations
Search
No results match your criteria
Filters
- Stock Market
- Stocks
- NOVN Stock
- News Novartis AG
- Broker Recommendations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition


















